Developer docs
API playgroundTry for free, no card

Search company profiles

Proteome Sciences

Full company profile

uuid000tvn8

Namestring
Proteome Sciences
Legal namestring
Proteome Sciences plc
Websiteurl
proteomics.com
Company typeenum
Public
Founded yearint
1994
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCobham, United Kingdom
HQ citystring
Cobham
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
proteomics services, protein biomarker discovery, mass spectrometry CRO, tandem mass tag reagents, clinical proteomics
Industry4 codes
PRIMARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Laboratory Analytical Instruments3826
Product category
Proteomics Contract Research Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1CRO Proteomics Services
TypeProfessional Services
Description

Full suite of Mass Spectrometric based protein discovery and detection services offered on an outsourced client-driven basis. Services include Discovery Proteomics, Targeted Proteomics, Speciality Proteomics, and bioinformatics. Revenue generated through project-based contracts with biopharma clients.

proteomics.com
2TMT Reagent Sales
TypeLicensing Royalties
Description

Manufacture and supply of TMT (Tandem Mass Tag) reagents - TMT 11-plex, TMTpro 18-plex and TMTpro 35-plex isobaric tags. Products sold exclusively through distribution partner ThermoFisher Scientific as part of their Mass Spectrometry consumable range.

proteomics.com
3GCLP Contract Services
TypeProfessional Services
Description

Good Clinical Laboratory Practice compliant contract services for clinical trial sample analysis. The company secured two GCLP contracts worth over $1.5 million, with trial samples shipping in late Q1 2026.

ukinvestormagazine.co.uk
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Proteome Sciences is a specialised Contract Research Organisation (CRO) offering a full suite of mass spectrometry-based protein discovery, validation and detection services on an outsourced client-driven basis. Its services span Discovery Proteomics (TMT LC-MS2/LC-MS3, SysQuant for PTMs, TMTcalibrator, Super Depletion), Targeted Proteomics (SRM/PRM, TMT-SRM) and Specialty Proteomics (Single Cell Proteomics, Peptidomics/MHC immunopeptidomics, IP Pull Down, Off-Gel Protein Sequencing, Protein Degrader/PROTAC assays), supported by computational proteomics and bioinformatics. The company also invented, developed and exclusively manufactures the proprietary TMT and TMTpro isobaric mass tag reagents (11-plex, 18-plex, 35-plex), which it sells globally through ThermoFisher Scientific.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Detects >8,500 proteins in plasma/serum
+4 more records
Product overview1 text field

Proteome Sciences is a Contract Research Organisation (CRO) offering a full suite of mass spectrometry-based proteomic services. The core offering centers on their proprietary Tandem Mass Tag (TMT) technology platform, with TMT 11-plex, TMTpro 18-plex, and newly launched TMTpro 35-plex reagents sold exclusively through Thermo Scientific. Their service portfolio spans Discovery Based Proteomics (TMT LC-MS2 and LC-MS3 workflows), SysQuant for global phosphoproteomics, TMTcalibrator for tissue-enhanced fluid biomarker discovery, and Super Depletion for plasma/serum analysis. Targeted services include SRM/PRM assays and TMT-SRM for biomarker validation, plus specialty services such as Single Cell Proteomics (SysQuant SCP), Peptidomics, IP Pull Downs, Off-Gel Protein Sequencing, and Protein Degrader/PROTAC Assays. All services include comprehensive Computational Proteomics and Bioinformatics analysis using ML/AI tools for data interpretation.

Product and service17 records
1TMT (Tandem Mass Tags) Reagents
CategoryReagent / Consumable Product
Description

Proprietary isobaric mass tagging reagents for multiplexed quantitative proteomics, including TMT 11-plex, TMTpro 18-plex and TMTpro 35-plex variants, sold as consumables to mass spectrometry laboratories worldwide via ThermoFisher Scientific.

2Discovery Based Proteomics Service
CategoryDiscovery Proteomics Service
Description

Unbiased TMT-based mass spectrometry discovery service for detecting and quantifying thousands of proteins from fluid and tissue samples across multiple species; the umbrella service into which TMT LC-MS2, TMT LC-MS3 and the SysQuant workflows sit.

3TMT LC-MS3 Service
CategoryDiscovery Proteomics Service
Description

High-accuracy quantitative proteomics workflow using TMT multiplexing with MS3 (SPS-MS3) fragmentation for enhanced precision, recommended for plasma biomarker discovery and complex samples.

4TMT LC-MS2 Service
CategoryDiscovery Proteomics Service
Description

Standard quantitative proteomics workflow combining TMT multiplexing with LC-MS2 mass spectrometry for broad proteome coverage in cells and tissues.

5SysQuant Service (Global Phosphoproteomics)
CategoryDiscovery Proteomics Service
Description

TMTpro-enabled workflow combining standard proteomic analysis with phospho- and other post-translational modification proteomics, simultaneously quantifying the proteome and specified PTMs (e.g. phosphorylation sites).

6TMTcalibrator Service
CategoryDiscovery Proteomics Service
Description

Tissue-enhanced biomarker discovery workflow that combines fluids and tissues using TMT multiplexing to bias biomarker discovery toward disease-related proteins in peripheral fluids such as CSF and plasma.

7Super Depletion Service
CategorySample Preparation Add-on Service
Description

Advanced immunoaffinity depletion of highly-abundant proteins (Top-14 and Top-65) from plasma/serum, enabling detection of over 8,500 proteins in plasma/serum when combined with TMTcalibrator.

8SRM/PRM Targeted Assays Service
CategoryTargeted Proteomics Service
Description

Targeted mass spectrometry assays for absolute biomarker quantitation using Selected Reaction Monitoring (SRM) or Parallel Reaction Monitoring (PRM) for validation of 1 to 100+ protein targets.

9TMT-SRM Service
CategoryTargeted Proteomics Service
Description

Combined TMT and SRM workflow enabling rapid validation of biomarker candidates identified in TMT discovery workflows in a single multiplexed assay.

10SysQuant SCP (Single Cell Proteomics) Service
CategorySpecialty Proteomics Service
Description

Mass spectrometry-based single cell proteomics service detecting 1,000-1,500 proteins per individual cell using TMTpro reagents and extensive mass spectrometric analysis across 576 cells per run.

11Peptidomics Service
CategorySpecialty Proteomics Service
Description

Analysis of endogenously created protein fragments including MHC I/II immunopeptidomics for immune cell therapy, neoantigen identification and peptide vaccine development.

12IP Pull Down Service
CategorySpecialty Proteomics Service
Description

Immuno-precipitation sample pre-treatment service for specific protein enrichment, protein complex isolation and ultra-sensitive assays when commercial antibodies are unavailable.

13Off-Gel Protein Sequencing Service
CategorySpecialty Proteomics Service
Description

Gel-based protein identification service for analysis of proteins from SDS-PAGE bands or 2D gel spots, including biotherapeutic characterisation.

14Protein Degrader / PROTAC Assays Service
CategorySpecialty Proteomics Service
Description

Multi-level analytical service supporting targeted protein degradation drugs: proteomics for target confirmation, peptidomics for degradation fragments, and enrichment proteomics for monitoring ubiquitination.

15Computational Proteomics Service (AI/ML)
CategoryBioinformatics Service
Description

Machine learning and AI-driven proteomics data analysis for biomarker discovery, pathway analysis and multi-omics integration to identify disease hallmarks and enable personalised treatment.

16Bioinformatics Package Service
CategoryBioinformatics Service
Description

Comprehensive computational proteomics and bioinformatics analysis including data normalisation, exploratory analysis, linear modelling and functional enrichment.

17GCLP-Compliant Clinical Targeted Assay Service
CategoryGCLP Clinical Proteomics Service
Description

Good Clinical Laboratory Practice (GCLP) compliant targeted proteomics assays run at the Frankfurt facility for clinical trial sample analysis, including the target engagement/chemoproteomics clinical contract.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive distribution partnership where ThermoFisher Scientific sells TMT and TMTpro reagents as part of their Mass Spectrometry consumable range globally. Proteome Sciences manufactures all TMT products in their Frankfurt laboratory while ThermoFisher handles global distribution and sales.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Proteomics platform company developing nanoparticle-based deep proteome profiling. Competes conceptually in deep plasma/serum proteomics, overlapping with Proteome Sciences' TMTcalibrator and Super Depletion workflows.

TypeBroad incumbent
Description

Global laboratory services group offering a wide range of bioanalytical and proteomics testing services. Adjacent competitor via breadth rather than proteomics specialization.

3Caprion Biosciences
TypeDirect peer
Description

Specialized proteomics and immune monitoring CRO offering biomarker discovery and validation services to biopharma. Comparable business model and customer base to Proteome Sciences.

TypeBroad incumbent
Description

Large CRO with extensive drug-discovery and preclinical services, including proteomics/biomarker capabilities within a much broader portfolio. Competes for the same biopharma budget as Proteome Sciences but at much greater scale.

TypeDirect peer
Description

US-based proteomics reagents and assay developer with strong antibody and immunoassay portfolio serving the same academic and biopharma research market. Overlaps with Proteome Sciences' targeted assay offering.

TypeDirect peer
Description

CRO offering mass spectrometry-based drug discovery services including protein characterization and target engagement assays. Comparable niche CRO positioning with biopharma clients.

TypeDirect peer
Description

Swiss contract research organisation specializing in mass spectrometry-based proteomics services (TrueDiscovery, TrueTarget, TrueSignature). Closest functional peer to Proteome Sciences' discovery and targeted proteomics CRO offering.

TypeDirect peer
Description

Swedish proteomics tools company offering proximity-extension assay-based protein biomarker reagents and services. Directly comparable as a proteomics-focused vendor selling into biopharma discovery and clinical research.

TypeEmerging player
Description

Emerging single-molecule proteomics platform company pursuing large-scale proteome quantification. Partial overlap with Proteome Sciences' SysQuant SCP single-cell proteomics service and adjacent to the broader proteomics market.

TypeBroad incumbent
Description

Major clinical and bioanalytical laboratory services provider with central lab and biomarker capabilities used by biopharma across clinical trials. Competes for clinical trial sample analysis work that Proteome Sciences targets through its GCLP service.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Proteome Sciences

Proteomics Contract Research Servicesproteomics.com

Proteome Sciences firmographics

Firmographics
Name
Proteome Sciences
Legal name
Proteome Sciences plc
Website
https://proteomics.com
Company type
Public
Founded year
1994
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Proteome Sciences industry classification

Industry
Product category
Proteomics Contract Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)

Keywords

  • Proteomics services
  • Protein biomarker discovery
  • Mass spectrometry CRO
  • Tandem mass tag reagents
  • Clinical proteomics

Where Proteome Sciences is headquartered

Location

Headquarters

HQ city
Cobham
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

Proteome Sciences business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. CRO Proteomics Services: Full suite of Mass Spectrometric based protein discovery and detection services offered on an outsourced client-driven basis. Services include Discovery Proteomics, Targeted Proteomics, Speciality Proteomics, and bioinformatics. Revenue generated through project-based contracts with biopharma clients.
  2. TMT Reagent Sales: Manufacture and supply of TMT (Tandem Mass Tag) reagents - TMT 11-plex, TMTpro 18-plex and TMTpro 35-plex isobaric tags. Products sold exclusively through distribution partner ThermoFisher Scientific as part of their Mass Spectrometry consumable range.
  3. GCLP Contract Services: Good Clinical Laboratory Practice compliant contract services for clinical trial sample analysis. The company secured two GCLP contracts worth over $1.5 million, with trial samples shipping in late Q1 2026.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Proteome Sciences product offering

Product offering

Core offering

Proteome Sciences is a specialised Contract Research Organisation (CRO) offering a full suite of mass spectrometry-based protein discovery, validation and detection services on an outsourced client-driven basis. Its services span Discovery Proteomics (TMT LC-MS2/LC-MS3, SysQuant for PTMs, TMTcalibrator, Super Depletion), Targeted Proteomics (SRM/PRM, TMT-SRM) and Specialty Proteomics (Single Cell Proteomics, Peptidomics/MHC immunopeptidomics, IP Pull Down, Off-Gel Protein Sequencing, Protein Degrader/PROTAC assays), supported by computational proteomics and bioinformatics. The company also invented, developed and exclusively manufactures the proprietary TMT and TMTpro isobaric mass tag reagents (11-plex, 18-plex, 35-plex), which it sells globally through ThermoFisher Scientific.

Product overview

Proteome Sciences is a Contract Research Organisation (CRO) offering a full suite of mass spectrometry-based proteomic services. The core offering centers on their proprietary Tandem Mass Tag (TMT) technology platform, with TMT 11-plex, TMTpro 18-plex, and newly launched TMTpro 35-plex reagents sold exclusively through Thermo Scientific. Their service portfolio spans Discovery Based Proteomics (TMT LC-MS2 and LC-MS3 workflows), SysQuant for global phosphoproteomics, TMTcalibrator for tissue-enhanced fluid biomarker discovery, and Super Depletion for plasma/serum analysis. Targeted services include SRM/PRM assays and TMT-SRM for biomarker validation, plus specialty services such as Single Cell Proteomics (SysQuant SCP), Peptidomics, IP Pull Downs, Off-Gel Protein Sequencing, and Protein Degrader/PROTAC Assays. All services include comprehensive Computational Proteomics and Bioinformatics analysis using ML/AI tools for data interpretation.

Differentiator

Problem solved

Functional benefit

Products and services

  • TMT (Tandem Mass Tags) Reagents Proprietary isobaric mass tagging reagents for multiplexed quantitative proteomics, including TMT 11-plex, TMTpro 18-plex and TMTpro 35-plex variants, sold as consumables to mass spectrometry laboratories worldwide via ThermoFisher Scientific.
  • Discovery Based Proteomics Service Unbiased TMT-based mass spectrometry discovery service for detecting and quantifying thousands of proteins from fluid and tissue samples across multiple species; the umbrella service into which TMT LC-MS2, TMT LC-MS3 and the SysQuant workflows sit.
  • TMT LC-MS3 Service High-accuracy quantitative proteomics workflow using TMT multiplexing with MS3 (SPS-MS3) fragmentation for enhanced precision, recommended for plasma biomarker discovery and complex samples.
  • TMT LC-MS2 Service Standard quantitative proteomics workflow combining TMT multiplexing with LC-MS2 mass spectrometry for broad proteome coverage in cells and tissues.
  • SysQuant Service (Global Phosphoproteomics) TMTpro-enabled workflow combining standard proteomic analysis with phospho- and other post-translational modification proteomics, simultaneously quantifying the proteome and specified PTMs (e.g. phosphorylation sites).
  • TMTcalibrator Service Tissue-enhanced biomarker discovery workflow that combines fluids and tissues using TMT multiplexing to bias biomarker discovery toward disease-related proteins in peripheral fluids such as CSF and plasma.
  • Super Depletion Service Advanced immunoaffinity depletion of highly-abundant proteins (Top-14 and Top-65) from plasma/serum, enabling detection of over 8,500 proteins in plasma/serum when combined with TMTcalibrator.
  • SRM/PRM Targeted Assays Service Targeted mass spectrometry assays for absolute biomarker quantitation using Selected Reaction Monitoring (SRM) or Parallel Reaction Monitoring (PRM) for validation of 1 to 100+ protein targets.
  • TMT-SRM Service Combined TMT and SRM workflow enabling rapid validation of biomarker candidates identified in TMT discovery workflows in a single multiplexed assay.
  • SysQuant SCP (Single Cell Proteomics) Service Mass spectrometry-based single cell proteomics service detecting 1,000-1,500 proteins per individual cell using TMTpro reagents and extensive mass spectrometric analysis across 576 cells per run.
  • Peptidomics Service Analysis of endogenously created protein fragments including MHC I/II immunopeptidomics for immune cell therapy, neoantigen identification and peptide vaccine development.
  • IP Pull Down Service Immuno-precipitation sample pre-treatment service for specific protein enrichment, protein complex isolation and ultra-sensitive assays when commercial antibodies are unavailable.
  • Off-Gel Protein Sequencing Service Gel-based protein identification service for analysis of proteins from SDS-PAGE bands or 2D gel spots, including biotherapeutic characterisation.
  • Protein Degrader / PROTAC Assays Service Multi-level analytical service supporting targeted protein degradation drugs: proteomics for target confirmation, peptidomics for degradation fragments, and enrichment proteomics for monitoring ubiquitination.
  • Computational Proteomics Service (AI/ML) Machine learning and AI-driven proteomics data analysis for biomarker discovery, pathway analysis and multi-omics integration to identify disease hallmarks and enable personalised treatment.
  • Bioinformatics Package Service Comprehensive computational proteomics and bioinformatics analysis including data normalisation, exploratory analysis, linear modelling and functional enrichment.
  • GCLP-Compliant Clinical Targeted Assay Service Good Clinical Laboratory Practice (GCLP) compliant targeted proteomics assays run at the Frankfurt facility for clinical trial sample analysis, including the target engagement/chemoproteomics clinical contract.

Quantifiable outcome

  • Detects >8,500 proteins in plasma/serum
  • +4 more outcomes

Companies that use Proteome Sciences

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Proteome Sciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

Proteome Sciences partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ThermoFisher ScientificcoreChannel Partner/ Reseller/ DistributorExclusive distribution partnership where ThermoFisher Scientific sells TMT and TMTpro reagents as part of their Mass Spectrometry consumable range globally. Proteome Sciences manufactures all TMT products in their Frankfurt laboratory while ThermoFisher handles global distribution and sales.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Proteome Sciences competitors and assessment

Company assessment

Emerging players

  • Seer: Proteomics platform company developing nanoparticle-based deep proteome profiling. Competes conceptually in deep plasma/serum proteomics, overlapping with Proteome Sciences' TMTcalibrator and Super Depletion workflows.
  • Nautilus Biotechnology: Emerging single-molecule proteomics platform company pursuing large-scale proteome quantification. Partial overlap with Proteome Sciences' SysQuant SCP single-cell proteomics service and adjacent to the broader proteomics market.

Broad incumbents

  • Eurofins Scientific: Global laboratory services group offering a wide range of bioanalytical and proteomics testing services. Adjacent competitor via breadth rather than proteomics specialization.
  • Charles River Laboratories: Large CRO with extensive drug-discovery and preclinical services, including proteomics/biomarker capabilities within a much broader portfolio. Competes for the same biopharma budget as Proteome Sciences but at much greater scale.
  • LabCorp (Covance): Major clinical and bioanalytical laboratory services provider with central lab and biomarker capabilities used by biopharma across clinical trials. Competes for clinical trial sample analysis work that Proteome Sciences targets through its GCLP service.

Direct peers

  • Caprion Biosciences: Specialized proteomics and immune monitoring CRO offering biomarker discovery and validation services to biopharma. Comparable business model and customer base to Proteome Sciences.
  • Cell Signaling Technology (CST): US-based proteomics reagents and assay developer with strong antibody and immunoassay portfolio serving the same academic and biopharma research market. Overlaps with Proteome Sciences' targeted assay offering.
  • Reaction Biology: CRO offering mass spectrometry-based drug discovery services including protein characterization and target engagement assays. Comparable niche CRO positioning with biopharma clients.
  • Biognosys: Swiss contract research organisation specializing in mass spectrometry-based proteomics services (TrueDiscovery, TrueTarget, TrueSignature). Closest functional peer to Proteome Sciences' discovery and targeted proteomics CRO offering.
  • Olink (Standard BioTools): Swedish proteomics tools company offering proximity-extension assay-based protein biomarker reagents and services. Directly comparable as a proteomics-focused vendor selling into biopharma discovery and clinical research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Proteome Sciences social profiles

Digital presence

Proteome Sciences compliance and trust

Trust signal

Compliance2 records

Proteome Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Proteome Sciences leadership team

Management profile

Number of profiles

Profiles6 records

Proteome Sciences subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Proteome Sciences funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Proteome Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Proteome Sciences

What does Proteome Sciences do?

Proteome Sciences is a specialised Contract Research Organisation (CRO) offering a full suite of mass spectrometry-based protein discovery, validation and detection services on an outsourced client-driven basis. Its services span Discovery Proteomics (TMT LC-MS2/LC-MS3, SysQuant for PTMs, TMTcalibrator, Super Depletion), Targeted Proteomics (SRM/PRM, TMT-SRM) and Specialty Proteomics (Single Cell Proteomics, Peptidomics/MHC immunopeptidomics, IP Pull Down, Off-Gel Protein Sequencing, Protein Degrader/PROTAC assays), supported by computational proteomics and bioinformatics. The company also invented, developed and exclusively manufactures the proprietary TMT and TMTpro isobaric mass tag reagents (11-plex, 18-plex, 35-plex), which it sells globally through ThermoFisher Scientific.

Is Proteome Sciences a public or private company?

Proteome Sciences is a public company. It is classified as public and is currently operating.

When was Proteome Sciences founded?

Proteome Sciences was founded in 1994. It employs 11 to 50 people.

Where is Proteome Sciences based?

Proteome Sciences is headquartered in Cobham, United Kingdom, in the Europe region.

How does Proteome Sciences make money?

Three revenue lines are on record. CRO Proteomics Services are the primary driver. The others are TMT Reagent Sales and GCLP Contract Services.

Who are Proteome Sciences's main competitors?

Emerging players on record are Seer and Nautilus Biotechnology. Broad incumbents are Eurofins Scientific, Charles River Laboratories and LabCorp (Covance). Direct peers are Caprion Biosciences, Cell Signaling Technology (CST), Reaction Biology, Biognosys and Olink (Standard BioTools).

Does Proteome Sciences have an API?

No public API is recorded for Proteome Sciences.

What industry is Proteome Sciences in?

Proteome Sciences's product category is Proteomics Contract Research Services. Its primary akta.pro industry code is HLAGANAB, Proteomics & Mass Spectrometry Services, with a secondary code of HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American Banking and Market NewsProteome Sciences (LON:PRM) Stock Price Breaks Above Two Hundred Day Moving Average – Time to Sell?Proteome Sciences shares traded above its 200-day moving average on Tuesday, reaching GBX 1.69. The company reported quarterly EPS of GBX 0.41, with a market cap of £4.24 million and a negative net margin of 61.46%.Investing.comProteome Sciences appoints Helen Spice as non-executive director By Investing.comProteome Sciences appointed Helen Spice as an independent non-executive director, effective immediately. Spice, 61, previously served as CFO of KPMG International and holds a non-executive role at Barts Health NHS Trust. She does not hold any ordinary shares, options, or warrants in the company.AdvfnProteome Sciences PLC Appointment of Non-Executive DirectorProteome Sciences plc appointed Helen Spice as an independent non-executive director with immediate effect. She brings strategic, financial, and accounting experience from her CFO role at KPMG and previous NHS trust directorships. She holds no shares or options in the company.InvestegateAppointment of Non-Executive DirectorProteome Sciences appointed Helen Spice as an independent non-executive director with immediate effect. She brings experience from KPMG and NHS trusts, and holds no shares in the company.Investing.comProteome Sciences secures third GCLP chemoproteomics contract By Investing.comProteome Sciences announced a clinical contract for its chemoproteomics platform, the third for the same protein in ongoing phase 1 and 2 trials. The project, conducted at Frankfurt labs, will begin sample shipments later this year with most work completed in 2027.Investing.comProteome Sciences secures third GCLP chemoproteomics contract By Investing.comProteome Sciences announced a clinical contract for its chemoproteomics platform, the third for the same protein in ongoing phase 1 and 2 trials. The project, conducted at Frankfurt labs, will begin sample shipments later this year, with most work completed in 2027.AdvfnProteome Sciences PLC Further GCLP Chemoproteomics contract securedProteome Sciences confirmed it secured a significant clinical contract for its GCLP-compliant chemoproteomics platform, to be performed at its Frankfurt laboratories. The contract supports phase 1 and 2 trials, with samples expected to ship later this year and most work completed in 2027.InvestegateFurther GCLP Chemoproteomics contract securedProteome Sciences secured a clinical contract for its GCLP-compliant chemoproteomics platform, its third for the same protein in ongoing phase 1 and 2 trials. Work will be done in Frankfurt, with sample shipments later this year and most completed in 2027. The company expects increased demand as complex drugs enter trials.Defense WorldProteome Sciences (LON:PRM) Shares Up 16.3% – Here’s What HappenedProteome Sciences plc (LON:PRM) shares rose 16.3% during mid-day trading on Friday, reaching GBX 1.50 from a previous close of GBX 1.29, with 210,243 shares traded. The company has a market capitalization of £5.26 million and reported quarterly revenue of GBX 376 million, though it posted a negative net margin of 81.50%. The stock's 50-day moving average stands at GBX 1.64, indicating the current price remains below recent averages.UK Investor MagazineAIM movers: Proteome Sciences wins two contracts and Gunsynd exploration disappointsProteome Sciences secured over $1.5m in contracts for contract proteomics services, with a significant proportion to be completed within the year. Mobility One received conditional approval to offer Islamic digital banking in Malaysia, with its stock rising significantly. Cadence Minerals obtained an environmental license for its Amapá mine project in Brazil, boosting its share price.